Dr. Ravi Patel

Hematology/oncology

Texas, United States

Dr. Patel practices at 2 locations. See details below.

About Dr. Patel

Dr. Patel is an Hematology/oncology Specialist in Keller and Grapevine, Texas. He graduated from University Of Wisconsin School Of Medicine in 2011. Dr. Patel accepts Medicare approved amount as full payment. 
The medical group (Texas Onco) Dr. Patel works with accepts Medicare approved amount as full payment.


Full Name
Ravi Patel

Specialty
Hematology/oncology
Internal Medicine, Medical Oncology

School
University Of Wisconsin School Of Medicine

Graduated class of
2011


NPI
1366736969

PAC ID
2147483647

Clinician Enrollment ID
I20170428000181
Cities

2

Number of cities where Dr. Patel has offices
Offices

2

Number of offices
Hospitals

1

Number of hospitals

Office Locations

KELLER Office

Phone: (817) 284-4994

100 Bourland Rd
Suite 130
Keller, TX - 76248-3595


GRAPEVINE Office

Phone: (817) 251-9080

1631 Lancaster Dr
Suite 150
Grapevine, TX - 76051-3586


Hospitals

BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE

CMS Certification Number: 450563

Doctors and Clinicians Utilization Data

SpecialtyHCPCS codeCode descriptionService Count Beneficiary count
Hematology/oncology 78815 Nuclear medicine study with CT imaging skull base to mid-thigh 42 38
Hematology/oncology 85025 Complete blood cell count (red cells, white blood cell, platelets), automated test 595 138
Hematology/oncology 96365 Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour 136 72
Hematology/oncology 96367 Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour 341 65
Hematology/oncology 96375 Injection of different drug or substance into a vein for therapy, diagnosis, or prevention 19 12
Hematology/oncology 96413 Infusion of chemotherapy into a vein up to 1 hour 214 59
Hematology/oncology G9678 Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation 180 33
Hematology/oncology J0897 Injection, denosumab, 1 mg 2280 14

Questions & Answers


Help others like you find out more about . Do you know the answers to any of these questions? Contribute now and help others like you.